Literature DB >> 26339350

Development of EBV-encoded small RNA targeted PCR to classify EBV positive diffuse large B-cell lymphoma (DLBCL) of the elderly.

Jaewang Lee1, Min Park2, Min Ho Lee2, Hyun Jun Woo2, Hyun-Woo Kim2, Ji Yeong Yang2, Yong-Bin Eom3, Sa-Hyun Kim4, Changyoung Yoo1, Jong-Bae Kim2.   

Abstract

Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly has been included in the 2008 WHO classification of lymphoma as a new provisional entity. EBV-positive DLBCL of the elderly is newly classified due to the main occurrence usually in patients of older than 50-year-old. This study was performed in 91 DLBCL patients from January 2002 to December 2012 in Catholic university of St. Vincent Hospital. Age distribution of the patients was 14~87-year-old. Specimens were collected from lymph nodes (n = 45) and extra-lymph nodes (n = 46). EBV encoded small RNA1 in situ hybridization (EBER1-ISH) known as a standard method for the diagnosis of DLBCL. In this study, nested PCR of DNA polymerase gene and EBER PCR were conducted to detect EBV. Presence of EBV was indicated in 3 samples (3.30%) by EBER-ISH, 26 samples (28.57%) by nPCR, and 3 samples (3.30%) by EBER PCR. The concordant results were obtained from EBER1-ISH and EBER PCR. Two samples were classified as EBV-positive DLBCL of the elderly among 91 DLBCL patients. Previously, the incidence rate of DLBCL of the elderly in Asia has been reported as 5~11%, but the result in this study showed a slightly lower incidence rate. To our knowledge, this is the first report on EBV-positive DLBCL of the elderly in Suwon area, Korea. EBER1-ISH and EBER PCR developed in this study may be helpful in classification of EBV-positive DLBCL of the elderly in future.

Entities:  

Keywords:  EBV-encoded small RNA; Epstein-Barr virus; diffuse large B-cell lymphoma

Mesh:

Substances:

Year:  2015        PMID: 26339350      PMCID: PMC4555678     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  30 in total

1.  Celastrol-induced apoptosis in human HaCaT keratinocytes involves the inhibition of NF-κB activity.

Authors:  Lin-Li Zhou; Zhi-Xiu Lin; Kwok-Pui Fung; Christopher H K Cheng; Chun-Tao Che; Ming Zhao; Shi-Hua Wu; Zhong Zuo
Journal:  Eur J Pharmacol       Date:  2011-09-21       Impact factor: 4.432

Review 2.  Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agents.

Authors:  Kwong-Fai Wong; Yi Yuan; John M Luk
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-03       Impact factor: 2.557

3.  Sodium arsenite and cadmium chloride induction of proteasomal inhibition and HSP accumulation in Xenopus laevis A6 kidney epithelial cells.

Authors:  Jara J Brunt; Saad Khan; John J Heikkila
Journal:  Comp Biochem Physiol C Toxicol Pharmacol       Date:  2011-10-01       Impact factor: 3.228

4.  Paraptosis accompanied by autophagy and apoptosis was induced by celastrol, a natural compound with influence on proteasome, ER stress and Hsp90.

Authors:  Wen-Bo Wang; Li-Xing Feng; Qing-Xi Yue; Wan-Ying Wu; Shu-Hong Guan; Bao-Hong Jiang; Min Yang; Xuan Liu; De-An Guo
Journal:  J Cell Physiol       Date:  2012-05       Impact factor: 6.384

5.  MRSA in children from foreign countries adopted to Swedish families.

Authors:  E B Gustafsson; H Ringberg; P J H Johansson
Journal:  Acta Paediatr       Date:  2007-01       Impact factor: 2.299

6.  Quinone methide tripterine, celastrol, induces apoptosis in human myeloma cells via NF-κB pathway.

Authors:  Keiichi Tozawa; Morihiko Sagawa; Masahiro Kizaki
Journal:  Int J Oncol       Date:  2011-08-17       Impact factor: 5.650

7.  Celastrus and its bioactive celastrol protect against bone damage in autoimmune arthritis by modulating osteoimmune cross-talk.

Authors:  Siddaraju M Nanjundaiah; Shivaprasad H Venkatesha; Hua Yu; Li Tong; Joseph P Stains; Kamal D Moudgil
Journal:  J Biol Chem       Date:  2012-05-01       Impact factor: 5.157

8.  Community-associated Panton-Valentine leukocidin-negative meticillin-resistant Staphylococcus aureus clone (ST72-MRSA-IV) causing healthcare-associated pneumonia and surgical site infection in Korea.

Authors:  E-J Joo; D R Chung; Y E Ha; S Y Park; S-J Kang; S H Kim; C-I Kang; K R Peck; N Y Lee; K S Ko; J-H Song
Journal:  J Hosp Infect       Date:  2012-05-30       Impact factor: 3.926

9.  [Nationwide investigation in Japan of the status of MRSA infections and usefulness of arbekacin].

Authors:  I Hayashi; M Inoue; H Hashimoto
Journal:  Jpn J Antibiot       Date:  1994-06

10.  Production and biological activity of laidlomycin, anti-MRSA/VRE antibiotic from Streptomyces sp. CS684.

Authors:  Jin Cheol Yoo; Jun Ho Kim; Jung Wan Ha; Nae Soo Park; Jae Kyung Sohng; June Woo Lee; Seong Chan Park; Mi Sun Kim; Chi Nam Seong
Journal:  J Microbiol       Date:  2007-02       Impact factor: 3.422

View more
  1 in total

Review 1.  Advances in the Pathogenesis of EBV-Associated Diffuse Large B Cell Lymphoma.

Authors:  Paola Chabay
Journal:  Cancers (Basel)       Date:  2021-05-31       Impact factor: 6.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.